Commentary: Evaluating the new dengue vaccine

Share                                                                                                                                                                        
TODAY newspaper published a commentary by LKCMedicine Professor of Infectious Diseases Annelies Wilder-Smith on the new dengue vaccine, in which she wrote that while there a number of vaccines – new and established ones such as the influenza vaccine – that can only reduce the number of infections, the reduction in disease burden despite a moderate efficacy could still be substantial for endemic diseases such as dengue. Prof Wilder-Smith added that for policymakers, how the disease affects the population – the economic costs, hospitalisations and deaths caused by the disease – is the most important factor in setting priorities for any vaccine to be introduced into public-sector immunisation programmes.
 
Media Reports
 
- TODAY, 25 May 2016